Moderna has withdrawn its application to approve the influenza-Covid-19 combination vaccine, intending to resubmit the application with additional data later
Miruna Brosban
Health
sursa foto: pexels.com
Always see our news on Google
The decision follows consultations with the FDA, which has requested new clinical trials for Covid-19 booster doses. Moderna shares fell 1.4% amid declining revenue from Covid-19 vaccines and concerns about the nomination of Robert F. Kennedy Jr. to be secretary of the Health Department. The FDA is expected to decide on the next-generation Covid-19 vaccine, part of the combination vaccine, with no anticipated delays.
Sources
Latest News
22:59
An Indian cargo ship sank in the Red Sea after an attack by Houthi rebels.
22:44
PHG Media Invest is in court against CNA for sanctions applied to Realitatea Plus
22:31
Unit 2 of the Cernavodă Nuclear Power Plant is operating normally under drought conditions.
22:16
Cuba: The UNE Company has announced the restoration of the national electric system, but many areas remain without power.
21:53
The Italian state, required to pay 260,000 euros to a Romanian woman illegally deprived of her liberty.
See more news
NEWS ON THE SAME TOPICS
.webp)
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
